The First Hospital of Qinhuangdao   Report issue

Academic/Hospital Phase 4
Founded: Qinhuangdao China (1948)

Organization Overview

First Clinical Trial
2016
NCT02961361
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

The First Hospital of Qinhuangdao | The First hosptial of Qinhuangdao

Active Ingredients

Drugs in Phase 4 Trials (2)

dexmedetomidine (precedex) (2 trials)

ropivacaine (naropin) (1 trial)

Drugs in Other Trials (2)

esketamine (spravato) (1 trial)

indocyanine green (ic-green) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arm Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4